Computational Design of Antibody-affinity Improvement Beyond in Vivo Maturation

Overview

Journal Nat Biotechnol

Specialty Biotechnology

Date 2007 Sep 25

PMID 17891135

Citations 164

Authors

Shaun M Lippow

K Dane Wittrup

Bruce Tidor

Affiliations

Soon will be listed here.

Abstract

Antibodies are used extensively in diagnostics and as therapeutic agents. Achieving high-affinity binding is important for expanding detection limits, extending dissociation half-times, decreasing drug dosages and increasing drug efficacy. However, antibody-affinity maturation in vivo often fails to produce antibody drugs of the targeted potency, making further affinity maturation in vitro by directed evolution or computational design necessary. Here we present an iterative computational design procedure that focuses on electrostatic binding contributions and single mutants. By combining multiple designed mutations, a tenfold affinity improvement to 52 pM was engineered into the anti-epidermal growth factor receptor drug cetuximab (Erbitux), and a 140-fold improvement in affinity to 30 pM was obtained for the anti-lysozyme model antibody D44.1. The generality of the methods was further demonstrated through identification of known affinity-enhancing mutations in the therapeutic antibody bevacizumab (Avastin) and the model anti-fluorescein antibody 4-4-20. These results demonstrate computational capabilities for enhancing and accelerating the development of protein reagents and therapeutics.

Citing Articles

Network pharmacology and in silico approaches to uncover multitargeted mechanism of action of Zingiber zerumbet rhizomes for the treatment of idiopathic pulmonary fibrosis.

Byregowda B, Baby K, Maity S, Nayak U, S G, Fayaz S F1000Res. 2025; 13:216.

PMID: 39931327 PMC: 11809647. DOI: 10.12688/f1000research.142513.1.

Combining computational modeling and experimental library screening to affinity-mature VEEV-neutralizing antibody F5.

Sumner C, Schwedler J, McCoy K, Holland J, Duva V, Gelperin D Protein Sci. 2025; 34(2):e70043.

PMID: 39840828 PMC: 11752144. DOI: 10.1002/pro.70043.

AntiFormer: graph enhanced large language model for binding affinity prediction.

Wang Q, Feng Y, Wang Y, Li B, Wen J, Zhou X Brief Bioinform. 2024; 25(5).

PMID: 39162312 PMC: 11333967. DOI: 10.1093/bib/bbae403.

An in silico investigation on the binding site preference of PD-1 and PD-L1 for designing antibodies for targeted cancer therapy.

Abdolmaleki S, Ganjalikhani Hakemi M, Ganjalikhany M PLoS One. 2024; 19(7):e0304270.

PMID: 39052609 PMC: 11271968. DOI: 10.1371/journal.pone.0304270.

Accurate prediction of CDR-H3 loop structures of antibodies with deep learning.

Chen H, Fan X, Zhu S, Pei Y, Zhang X, Zhang X Elife. 2024; 12.

PMID: 38921957 PMC: 11208048. DOI: 10.7554/eLife.91512.

References

Midelfort K, Wittrup K . Context-dependent mutations predominate in an engineered high-affinity single chain antibody fragment. Protein Sci. 2006; 15(2):324-34. PMC: 2242459. DOI: 10.1110/ps.051842406. View

Korkegian A, Black M, Baker D, Stoddard B . Computational thermostabilization of an enzyme. Science. 2005; 308(5723):857-60. PMC: 3412875. DOI: 10.1126/science.1107387. View

Sood V, Baker D . Recapitulation and design of protein binding peptide structures and sequences. J Mol Biol. 2006; 357(3):917-27. DOI: 10.1016/j.jmb.2006.01.045. View

Clark L, Boriack-Sjodin P, Eldredge J, Fitch C, Friedman B, Hanf K . Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design. Protein Sci. 2006; 15(5):949-60. PMC: 2242497. DOI: 10.1110/ps.052030506. View

Wagoner J, Baker N . Assessing implicit models for nonpolar mean solvation forces: the importance of dispersion and volume terms. Proc Natl Acad Sci U S A. 2006; 103(22):8331-6. PMC: 1482494. DOI: 10.1073/pnas.0600118103. View

Ashworth J, Havranek J, Duarte C, Sussman D, Monnat Jr R, Stoddard B . Computational redesign of endonuclease DNA binding and cleavage specificity. Nature. 2006; 441(7093):656-9. PMC: 2999987. DOI: 10.1038/nature04818. View

Joachimiak L, Kortemme T, Stoddard B, Baker D . Computational design of a new hydrogen bond network and at least a 300-fold specificity switch at a protein-protein interface. J Mol Biol. 2006; 361(1):195-208. DOI: 10.1016/j.jmb.2006.05.022. View

Joughin B, Green D, Tidor B . Action-at-a-distance interactions enhance protein binding affinity. Protein Sci. 2005; 14(5):1363-9. PMC: 2253263. DOI: 10.1110/ps.041283105. View

Cochran F, Wu S, Wang W, Nanda V, Saven J, Therien M . Computational de novo design and characterization of a four-helix bundle protein that selectively binds a nonbiological cofactor. J Am Chem Soc. 2005; 127(5):1346-7. DOI: 10.1021/ja044129a. View

10.

Presta L, Chen H, OConnor S, Chisholm V, Meng Y, Krummen L . Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res. 1997; 57(20):4593-9. View

11.

Dahiyat B, Mayo S . De novo protein design: fully automated sequence selection. Science. 1997; 278(5335):82-7. DOI: 10.1126/science.278.5335.82. View

12.

Desjarlais J, Handel T . De novo design of the hydrophobic cores of proteins. Protein Sci. 1995; 4(10):2006-18. PMC: 2142989. DOI: 10.1002/pro.5560041006. View

13.

Foote J, Eisen H . Kinetic and affinity limits on antibodies produced during immune responses. Proc Natl Acad Sci U S A. 1995; 92(5):1254-6. PMC: 42497. DOI: 10.1073/pnas.92.5.1254. View

14.

Sato J, Kawamoto T, Le A, Mendelsohn J, Polikoff J, Sato G . Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. Mol Biol Med. 1983; 1(5):511-29. View

15.

Dwyer M, Looger L, Hellinga H . Computational design of a biologically active enzyme. Science. 2004; 304(5679):1967-71. DOI: 10.1126/science.1098432. View

16.

Gallicchio E, Levy R . AGBNP: an analytic implicit solvent model suitable for molecular dynamics simulations and high-resolution modeling. J Comput Chem. 2004; 25(4):479-99. DOI: 10.1002/jcc.10400. View

17.

Levy R, Zhang L, Gallicchio E, Felts A . On the nonpolar hydration free energy of proteins: surface area and continuum solvent models for the solute-solvent interaction energy. J Am Chem Soc. 2003; 125(31):9523-30. DOI: 10.1021/ja029833a. View

18.

Looger L, Dwyer M, Smith J, Hellinga H . Computational design of receptor and sensor proteins with novel functions. Nature. 2003; 423(6936):185-90. DOI: 10.1038/nature01556. View

19.

Havranek J, Harbury P . Automated design of specificity in molecular recognition. Nat Struct Biol. 2002; 10(1):45-52. DOI: 10.1038/nsb877. View

20.

Reina J, Lacroix E, Hobson S, Fernandez-Ballester G, Rybin V, Schwab M . Computer-aided design of a PDZ domain to recognize new target sequences. Nat Struct Biol. 2002; 9(8):621-7. DOI: 10.1038/nsb815. View